Analyst Ratings for Corvus Pharmaceuticals (CRVS)

CRVS Rating Summary

CRVS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CRVS
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $6.00 (+110.5%) * Over Last 12-Mos
Rating Score: 8.9 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/10/2021 Mizuho Securities Mara Goldstein Downgrade Neutral
(Buy)
4.00
(N/A)
4.28
(2.85)
-33.41% Details
3/10/2020 H.C. Wainwright N/A New Coverage Buy
(N/A)
10.00
(N/A)
2.72
(2.85)
4.78% Details
Like CRVS Ratings? Also take a look at AUTL, INCY, IOVA, RCUS

CRVS Ratings News